---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-004161"
form_type: "8-K"
ticker: "IBO"
cik: "0001834105"
company_name: "IMPACT BIOMEDICAL INC."
filed_at: "2025-01-29T23:59:59+00:00"
generated_at: "2026-05-27T07:15:08.119584+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.0
calibrated_materiality_score: 0.0
confidence: "low"
source: SEC EDGAR
---

# Impact Biomedical CEO presents investor slide deck on Jan 29, 2025; no details available

## Summary
- Slide package furnished as Exhibit 99.1 not included in filing text; no specifics provided.
- CEO Frank D. Heuszel provided investor information on January 29, 2025.
- No financial metrics, guidance, or operational updates disclosed in the filing body.

## SEC filing metadata
- accession: 0001493152-25-004161
- form_type: 8-K
- ticker: IBO
- cik: 0001834105
- company_name: IMPACT BIOMEDICAL INC.
- filed_at: 2025-01-29T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.0
- calibrated_materiality_score: 0.0
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1834105/000149315225004161/0001493152-25-004161-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1834105/000149315225004161/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-004161
- JSON: https://secwatch.observer/filing/0001493152-25-004161.json
- Plain text: https://secwatch.observer/filing/0001493152-25-004161.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.